Cardinal Point Capital Management ULC cut its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 78.2% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 547 shares of the semiconductor company’s stock after selling 1,960 shares during the period. Cardinal Point Capital Management ULC’s holdings in Synopsys were worth $217,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Ritholtz Wealth Management lifted its holdings in Synopsys by 21.1% in the first quarter. Ritholtz Wealth Management now owns 1,487 shares of the semiconductor company’s stock valued at $589,000 after acquiring an additional 259 shares during the period. Global Financial Private Client LLC increased its position in shares of Synopsys by 84.6% during the 1st quarter. Global Financial Private Client LLC now owns 1,246 shares of the semiconductor company’s stock valued at $494,000 after purchasing an additional 571 shares during the last quarter. Blue Trust Inc. increased its position in shares of Synopsys by 34.0% during the 1st quarter. Blue Trust Inc. now owns 1,479 shares of the semiconductor company’s stock valued at $586,000 after purchasing an additional 375 shares during the last quarter. Fifth Third Wealth Advisors LLC lifted its stake in shares of Synopsys by 46.8% in the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,343 shares of the semiconductor company’s stock worth $929,000 after purchasing an additional 747 shares during the period. Finally, OP Asset Management Ltd purchased a new position in shares of Synopsys in the first quarter worth approximately $13,013,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Synopsys Stock Performance
Shares of NASDAQ SNPS opened at $455.02 on Friday. The stock has a market cap of $87.13 billion, a PE ratio of 105.33, a price-to-earnings-growth ratio of 2.73 and a beta of 1.22. Synopsys, Inc. has a 1 year low of $376.18 and a 1 year high of $651.73. The firm has a fifty day moving average price of $483.35 and a 200-day moving average price of $462.20. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32.
Analyst Ratings Changes
Several research firms have weighed in on SNPS. Piper Sandler upgraded shares of Synopsys from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $450.00 to $550.00 in a research report on Tuesday. Needham & Company LLC restated a “buy” rating and issued a $580.00 price objective on shares of Synopsys in a research note on Thursday, May 28th. Berenberg Bank set a $633.00 target price on Synopsys in a report on Wednesday, May 27th. Stifel Nicolaus lifted their target price on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Finally, Citigroup boosted their price target on Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Ten equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Synopsys has a consensus rating of “Moderate Buy” and an average price target of $570.06.
Read Our Latest Research Report on SNPS
Insider Transactions at Synopsys
In other news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at $34,431,179.20. This trade represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by company insiders.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
